Headache type | Drugs implied |
---|---|
1. Headache as type-A adverse drug reaction: predictable, related to the principal pharmacological action of the drugs, and dose-dependent | Nitric oxide (NO) donors (code 8.1.1), Phosphodiesterase (PDE) inhibitors (code 8.1.2), Calcitonin gene-related peptide-CGRP (code 8.1.9), Cocaine (code 8.1.6), Ethanol (code 8.1.4), Cannabis (code 8.1.7), Histamine (code 8.1.8), Calcium-channel blockers (Table 1 in the appendix), Antiarrhytmics, β-Adrenergic blockers, Ace inhibitors, Sympathomimetics (code 10.3.6), Antagonists of the at-1 receptors for Angiotensin II, Statins, α2-Adrenergic agonist (Clonidine), α1-Adrenergic blockers (Doxazosin and Prazosin), Amiloride, Methylxanthines, β2-Adrenergic agonists, Agents for erectile dysfunction, Ergotamine (Table 1 in the appendix), Nicotine (code 8.1.10), Amphetamine (code 10.3.6) |
2. Headache as type-B adverse drug reaction: idiosyncratic, unpredictable, and related to aseptic meningitis (code 7.3.2) | Amoxicillin, Carbamazepine, Diclofenac, Famotidine, Ibuprofen, Immune globulin, Infliximab, Ketorolac, Leflunomide, Levamisole, Metronidazole, Naproxen, Ranitidine, Rofecoxib, Sulfamethoxazole, Sulfasalazine, Sulindac, Tolmetin, Trimethoprim, Valacyclovir |
3. Headache as type-C adverse drug reaction: after chronic medication, related to raised intracranial pressure (code 8.3 and code 7.1.2) | Amiodarone, Anabolic steroids, Contraceptives Combination, Ciprofloxacin, Danazol, Corticosteroids, Gentamicin, Lithium Carbonate, Nalidixic Acid, Nitrofurantoin, Ofloxacin, Retinoic Acid, Tetracycline, Thyroid hormone replacement, Vitamin A |
4. Headache as type-E adverse drug reaction: related to substance withdrawal | Caffeine-withdrawal headache (code 8.4.1), Opioid-withdrawal headache (code 8.4.2), estrogen-withdrawal headache (code 8.4.3), Ergotamine-withdrawal headache, Cocaine-withdrawal headache, Methysergide-withdrawal headache |